In this review, we will discuss multidisciplinary considerations in treating patients with neoadjuvant therapy and highlight areas of controversy and ongoing research.
Susan Harvey, MD
Advertisement
Articles by Susan Harvey, MD
Advertisement
Latest Updated Articles
Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future DirectionsPublished: November 16th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma
4
What Were The Most Impactful GU Oncology Data From ESMO 2025?
5
